Shared publicly  - 
 
Xconomy: Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs http://www.xconomy.com/seattle/2012/04/19/alder-biopharma-snags-38m-to-push-ahead-with-antibody-drugs/
Alder Biopharmaceuticals has nailed down the biggest round of venture capital the Seattle biotech community has seen in a long time. The Bothell, WA-based
1
Laura Strong's profile photoKevin Chow's profile photo
 
Thanks again, Laura! Excited to have Novo involved now.
Add a comment...